Cell-based screening system
cell-based screening of new drug candidates, ADME/Tox and assay
development.
Germany's CyBio has launched a new liquid handling and detection platform that is suitable for use in assay development, primary and secondary screening of drug candidates and ADME/Tox (absorption, distribution metabolism, excretion and toxicology) applications.
The CyBi-Cellight system is based on CyBio's well-established plate handling and transport system and includes on-line incubation, scheduling software and the company's recently-launched CyBi-SIENA quality control software module used to detect and correct systematic error in high-throughput screening (HTS) data sets. It is compatible with a broad range of reader devices, according to the firm.
"CyBi-Cellight … will be especially valuable for labs who like to change between fluorescent and luminescent assays depending on the specific application," said Christopher Groves, CyBio's marketing manager.
The platform has an open design that provides users with flexibility with detection modes, plate density, incubation parameters, and assay/automation scheduling, according to CyBio.
